Home / Market Reports / Medical Devices & Consumables
/ Global Monocyte Activation Test Market Growth (Status and Outlook) 2025-2031
Global Monocyte Activation Test Market Growth (Status and Outlook) 2025-2031
Product Code:1483437
Published Date: Apr 14,2025
Pages: 95
Region: Global
Category: Medical Devices & Consumables
PDF DOWNLOAD
GET FREE SAMPLE
CUSTOMIZE REQUEST
PDF DOWNLOAD
GET FREE SAMPLE
CUSTOMIZE REQUEST
Provide comprehensive and accurate analysis and reports according to your exact requirements
The global Monocyte Activation Test market size is predicted to grow from US$ 98 million in 2025 to US$ 304 million in 2031; it is expected to grow at a CAGR of 20.7% from 2025 to 2031.
Monocyte Activation Test (MAT) is an in vitro detection method. The monocyte activation test is based on the biological characteristics of monocytes or monocyte cell lines that release a series of proinflammatory cytokines (such as TNF-α, IL-1β, IL-6, etc.) after being stimulated by exogenous pyrogens (such as endotoxins). These proinflammatory cytokines are key indicators for evaluating whether monocytes are activated.
The main purpose of the monocyte activation test is to evaluate whether there are contaminants in the test sample that can activate monocytes to release proinflammatory cytokines, such as endotoxins, bacteria, viruses, fungi, etc. These contaminants may cause adverse reactions such as fever in the human body, so the monocyte activation test is of great significance in the safety evaluation of drugs, biological products, medical devices and other fields.
With the development of the medical industry and the improvement of people's health awareness, the safety requirements for drugs and biological products are becoming increasingly stringent. As an important means to evaluate whether there are potential pyrogens in drugs and biological products, the market demand for monocyte activation test has also increased. Medical devices may be contaminated by microorganisms during production and use, and monocyte activation test can be used to evaluate their safety. With the continuous expansion of the medical device market and the improvement of regulatory requirements, the demand for monocyte activation test is also continuing to grow.
With the development of related disciplines such as biotechnology and immunology, the technical level of monocyte activation test has been continuously improved, providing strong support for the expansion of the market. At the same time, the government's policies on medical safety, drug supervision and other aspects are also constantly improving, providing a good policy environment for the healthy development of the monocyte activation test market.
LPI (LP Information)' newest research report, the “Monocyte Activation Test Industry Forecast” looks at past sales and reviews total world Monocyte Activation Test sales in 2024, providing a comprehensive analysis by region and market sector of projected Monocyte Activation Test sales for 2025 through 2031. With Monocyte Activation Test sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Monocyte Activation Test industry.
This Insight Report provides a comprehensive analysis of the global Monocyte Activation Test landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Monocyte Activation Test portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Monocyte Activation Test market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Monocyte Activation Test and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Monocyte Activation Test.
This report presents a comprehensive overview, market shares, and growth opportunities of Monocyte Activation Test market by product type, application, key players and key regions and countries.
Segmentation by Type:
MAT Kits
Reagents
Segmentation by Application:
Pharmaceutical Industry
Biotechnology Industry
Medical Device Industry
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Merck KGaA
Thermo Fisher Scientific
Mindray
Microcoat Biotechnologie GmbH
Charles River Laboratories International, Inc.
Becton, Dickinson and Company
Lonza Group
SOLVIAS AG
Landfar